With many years of experience in supporting regulatory compliant clinical research, we are ideally placed to advise our clients in making more informed decisions around the selection and use of imaging and digital biomarkers. We can work as an integral part of our clients own teams and within collaborative consortia to identify, develop and deliver solutions that reduce risk and increase the impact and value of our client’s assets.

Define an appropriate imaging strategy to optimise and de-risk deployment into your clinical trial. Our expertise includes structural and functional MRI, PET and SPECT


Apply our analytical capabilities to perform retrospective analysis on clinical data sets to:

  • Simplify and advance the reliability of endpoint measures
  • Develop screening and segmentation strategies to improve clinical trial efficiency

Advise on the suitability of digital biosensor measures to improve the measurement of clinical outcomes, and on the regulatory pathway to successfully use these measures in registration studies.

To speak to one of our experts and find out more